Search results
Results From The WOW.Com Content Network
Bipolar disorder. Bipolar disorder is characterized by episodes of depression and hypomania or mania. Bipolar disorder, previously known as manic depression, is a mental disorder characterized by periods of depression and periods of abnormally elevated mood that each last from days to weeks. [ 4][ 5] If the elevated mood is severe or associated ...
Maintenance therapy with antipsychotic drugs is clearly superior to placebo in preventing relapse but is associated with weight gain, movement disorders, and high dropout rates. [38] A 3-year trial following persons receiving maintenance therapy after an acute psychotic episode found that 33% obtained long-lasting symptom reduction, 13% ...
The atypical antipsychotics ( AAP ), also known as second generation antipsychotics ( SGAs) and serotonin –dopamine antagonists ( SDAs ), [ 1][ 2] are a group of antipsychotic drugs (antipsychotic drugs in general are also known as tranquilizers and neuroleptics, although the latter is usually reserved for the typical antipsychotics) largely ...
Quetiapine, sold under the brand name Seroquel among others, is an atypical antipsychotic medication used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder. [ 9 ] [ 10 ] Despite being widely used as a sleep aid due to its sedating effect, the benefits of such use may not outweigh its undesirable side effects ...
Risperidone. Risperidone, sold under the brand name Risperdal among others, is an atypical antipsychotic [ 2] used to treat schizophrenia and bipolar disorder. [ 2] It is taken either by mouth or by injection (subcutaneous or intramuscular). [ 2] The injectable versions are long-acting and last for 2–4 weeks.
163 million (2017) [ 8] Major depressive disorder ( MDD ), also known as clinical depression, is a mental disorder [ 9] characterized by at least two weeks of pervasive low mood, low self-esteem, and loss of interest or pleasure in normally enjoyable activities. Introduced by a group of US clinicians in the mid-1970s, [ 10] the term was adopted ...
Empirical evidence, combined with treatment considerations, led the DSM-IV Mood Disorders Work Group to add BP-II as its own entity in the 1994 publication. Only one other mood disorder was added to this edition, indicating the conservative nature of the DSM-IV work group. In May 2013, the DSM-5 was released. Two revisions to the existing BP-II ...
The DSM-5 defines atypical depression as a subtype of major depressive disorder that presents with "atypical features", characterized by: Mood reactivity (i.e., mood brightens in response to actual or potential positive events) At least two of the following: Significant weight gain or increase in appetite (hyperphagia);